Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-11-08

Clinical Trial Update: Nitropaste in Breast Reduction [Phase 3]

View source ↗

Summary

Phase 3 trial of Nitropaste for gynecomastia and delayed wound healing was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitropaste

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Gynecomastia, Delayed Wound Healing | Phase 3 | Status: WITHDRAWN